mirtazapine has been researched along with Polydipsia in 1 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Polydipsia: Excessive thirst manifested by excessive fluid intake. It is characteristic of many diseases such as DIABETES MELLITUS; DIABETES INSIPIDUS; and NEPHROGENIC DIABETES INSIPIDUS. The condition may be psychogenic in origin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lim, SY | 1 |
| Bodagh, N | 1 |
| Scott, G | 1 |
| Hill, NE | 1 |
1 other study available for mirtazapine and Polydipsia
| Article | Year |
|---|---|
Hyponatraemia: the importance of obtaining a detailed history and corroborating point-of-care analysis with laboratory testing.
Topics: Aged; Confusion; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Medical History Taking; Mir | 2019 |